Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study-Reference-Cited by-同舟云学术

Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study

Published:2014-01-07 Issue:3 Volume:143 Page:485-492
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

McCullough Ann E.,Dell’Orto Patrizia,Reinholz Monica M.,Gelber Richard D.,Dueck Amylou C.,Russo Leila,Jenkins Robert B.,Andrighetto Stefania,Chen Beiyun,Jackisch Christian,Untch Michael,Perez Edith A.,Piccart-Gebhart Martine J.,Viale Giuseppe

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-013-2827-0.pdf

Reference10 articles.

1. Perez EA, Romond EH, Suman VJ et al (2011) Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31. J Clin Oncol 29:3366–3373

2. Viale G, Regan MM, Maiorano E et al (2007) Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98. J Clin Oncol 25:3846–3852

3. Wolff AC, Hammond ME, Schwartz JN et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118–145

4. Hammond ME, Hayes DF, Dowsett M et al (2010) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med 134:e48–e72

5. Dako product insert for Dako ER/PR pharmDX kit for the Dako Autostainer, edition 10/11

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular testing in breast cancer;Diagnostic Molecular Pathology;2024

2. Pyrotinib in combination with first-line trastuzumab and docetaxel for patients with HER2-positive metastatic breast cancer: a new therapeutic option?;Nature Reviews Clinical Oncology;2023-12-19

3. Concordance of RT-qPCR with immunohistochemistry and its beneficial role in breast cancer subtyping;Medicine;2023-09-22

4. Correlation of ER, PR, and HER2 at the protein and mRNA levels in Asian patients with operable breast cancer;Bioscience Reports;2022-01

5. Clinicopathological features and prognosis of male breast cancer;Journal of International Medical Research;2021-10